Journal article
Optimising parameters for peripheral blood leukapheresis after r-metHuG-CSF (filgrastim) and r-metHuSCF (ancestim) in patients with multiple myeloma: a temporal analysis of CD34+ absolute counts and subsets
Abstract
Patients (n = 69) with multiple myeloma undergoing peripheral blood stem cell collection (PBSC) were treated with cyclophosphamide and a combination of recombinant methionyl human granulocyte colony-stimulating factor (r-metHuG-CSF, filgrastim) and recombinant methionyl human stem cell factor (r-metHuSCF, ancestim). The objectives of this study were to determine: (1) The proportion of patients reaching a target yield of ⩾5 × 106 CD34+ cells/kg …
Authors
Chin-Yee I; Keeney M; Stewart A; Belch A; Bence-Buckler I; Couban S; Howson-Jan K; Rubinger M; Stewart D; Sutherland R
Journal
Bone Marrow Transplantation, Vol. 30, No. 12, pp. 851–860
Publisher
Springer Nature
Publication Date
December 1, 2002
DOI
10.1038/sj.bmt.1703765
ISSN
0268-3369